STAT3 and familial dilated cardiomyopathy: After potential target screening, six DCM-associated targets of triptolide were identified (STAT3, VEGFA, FOS, TNF, TP53, and TGFB1), suggesting that these targets may play key roles in the treatment of DCM by triptolide.